Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call

Reuters

05-27

Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call

Pfizer Inc. held its first-quarter 2025 earnings conference call on April 29, 2025, where the company's leadership discussed their latest financial results and strategic priorities. The event was attended by key executives, including Francesca DeMartino, Chief Investor Relations Officer; Dr. Albert Bourla, Chairman and CEO; and Dave Denton, CFO. Analysts from various financial institutions also participated in the call. During the call, Dr. Albert Bourla expressed satisfaction with the company's performance, stating, "We are very pleased with our performance in the first quarter as we continue to execute with focus and discipline on our strategic priorities." The discussion highlighted Pfizer's commitment to maintaining a robust financial standing and the ongoing execution of its strategic initiatives. The call also covered forward-looking statements and emphasized the importance of reviewing the disclaimers and disclosures available on Pfizer's website. The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief on May 26, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2538107658"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2538107658\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2538107658?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-27 01:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2538107658","market":"nz","top_or_hot":-1,"title":"Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Pfizer Inc. held its first-quarter 2025 earnings conference call on April 29, 2025, where the company's leadership discussed their latest financial results and strategic priorities. The event was attended by key executives, including Francesca DeMartino, Chief Investor Relations Officer; Dr. Albert Bourla, Chairman and CEO; and Dave Denton, CFO. Analysts from various financial institutions also participated in the call. During the call, Dr. Albert Bourla expressed satisfaction with the company's performance, stating, \"We are very pleased with our performance in the first quarter as we continue to execute with focus and discipline on our strategic priorities.\" The discussion highlighted Pfizer's commitment to maintaining a robust financial standing and the ongoing execution of its strategic initiatives. The call also covered forward-looking statements and emphasized the importance of reviewing the disclaimers and disclosures available on Pfizer's website. The full transcript can be accessed through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief on May 26, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Inc. Releases Transcript of Q1 2025 Earnings Call\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-27 01:29</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Pfizer Inc. held its first-quarter 2025 earnings conference call on April 29, 2025, where the company's leadership discussed their latest financial results and strategic priorities. The event was attended by key executives, including Francesca DeMartino, Chief Investor Relations Officer; Dr. Albert Bourla, Chairman and CEO; and Dave Denton, CFO. Analysts from various financial institutions also participated in the call. During the call, Dr. Albert Bourla expressed satisfaction with the company's performance, stating, \"We are very pleased with our performance in the first quarter as we continue to execute with focus and discipline on our strategic priorities.\" The discussion highlighted Pfizer's commitment to maintaining a robust financial standing and the ongoing execution of its strategic initiatives. The call also covered forward-looking statements and emphasized the importance of reviewing the disclaimers and disclosures available on Pfizer's website. The full transcript can be accessed through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief on May 26, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"輝瑞","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250526:nNDLbvTWmz:1","article_id":"2538107658","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2538107658","pubTimestamp":1748280548,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Pfizer Inc. held its first-quarter 2025 earnings conference call on April 29, 2025, where the company's leadership discussed their latest financial results and strategic priorities. The event was attended by key executives, including Francesca DeMartino, Chief Investor Relations Officer; Dr. Albert Bourla, Chairman and CEO; and Dave Denton, CFO. Analysts from various financial institutions also participated in the call. During the call, Dr. Albert Bourla expressed satisfaction with the company's performance, stating, \"We are very pleased with our performance in the first quarter as we continue to execute with focus and discipline on our strategic priorities.\" The discussion highlighted Pfizer's commitment to maintaining a robust financial standing and the ongoing execution of its strategic initiatives. The call also covered forward-looking statements and emphasized the importance of reviewing the disclaimers and disclosures available on Pfizer's website. The full transcript can be acce","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞公司发布2025年第一季度收益看涨期权记录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"Pfizer Inc. Releases Transcript of Q1 2025 Earnings Call\n    \n\n        Pfizer Inc. held its first-quarter 2025 earnings conference call on April 29, 2025, where the company's leadership discussed their latest financial results and strategic priorities. The event was attended by key executives, including Francesca DeMartino, Chief Investor Relations Officer; Dr. Albert Bourla, Chairman and CEO; and Dave Denton, CFO. Analysts from various financial institutions also participated in the call. During the call, Dr. Albert Bourla expressed satisfaction with the company's performance, stating, \"We are very pleased with our performance in the first quarter as we continue to execute with focus and discipline on our strategic priorities.\" The discussion highlighted Pfizer's commitment to maintaining a robust financial standing and the ongoing execution of its strategic initiatives. The call also covered forward-looking statements and emphasized the importance of reviewing the disclaimers and disclosures available on Pfizer's website. The full transcript can be accessed through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief on May 26, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}